Table 2.
Assessment of moderate-risk heart disease.
| Without risk | Moderate risk | High risk | ||||
|---|---|---|---|---|---|---|
| Nb | % | Nb | % | Nb | % | |
| Non-cyanogenic congenital heart disease | 16 | (19.5) | 41 | (50) | 23 | (30.5) |
| Mitral valve prolapse | 5 | (6.1) | 38 | (45.3) | 39 | (47.6) |
| Hypertrophic cardiomyopathy | 20 | (23.4) | 37 | (45.1) | 25 | (30.5) |
| Patient with stable prosthetic heart valve | 25 | (30.5) | 39 | (47.6) | 18 | (22) |
| History of myocardial infarction less than 6 months old | 6 | (7.3) | 19 | (23.2) | 57 | (69.5) |
| Aortic bicuspidia | 16 | (19.5) | 50 | (61) | 12 | (19.5) |
| Valvular heart disease (aortic insufficiency, mitral insufficiency, atrial stenosis) | 3 | (3.7) | 27 | (32.9) | 52 | (63.4) |
| Aortic stenosis | 21 | (25.6) | 30 | (36.6) | 31 | (37.8) |